Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Título del estudio: Estudio de Fase 1/2, abierto, multicéntrico, para la determinación yexpansión de dosis para investigar la se

Título del estudio: Estudio de Fase 1/2, abierto, multicéntrico, para la determinación yexpansión de dosis para investigar la seguridad, tolerabilidad y eficacia de la terapiagénica ALXN2350 en participantes adultos con miocardiopatía dilatada relacionadacon la mutación BAG3Estudio de rendimiento de ARUP Laboratories: Prueba AAV9 TAb para la elegibilidad en elensayo clínico ALXN2350-DCM-201Estudio de rendimiento de AMBRY: Protocolo de estudio de rendimiento clínico para el usode la prueba BAG3Next para la inclusión de pacientes en un estudio de fase 1/2, abierto,multicéntrico que investiga la seguridad, tolerabilidad y eficacia de la terapia génica ALXN2350en participantes adultos con miocardiopatía dilatada relacionada con la mutación BAG3.

Contact
  • Protocol code: ALXN2350-DCM-201
  • EudraCT code: No aplica
  • Pathology: Malalties del sistema circulatori
  • Principal investigator:  Limeres Freire, Javier
  • Research group:  Malalties cardiovasculars
  • Service: Cardiologia
  • Phase: Fase I
  • Recruiting: Closed
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.